On Monday, President Trump and HHS Secretary Robert F. Kennedy Jr. revealed that the FDA will inform doctors about potential connections between acetaminophen use during pregnancy and a notably heightened risk of neurological issues in children, such as autism and ADHD.
This announcement has sparked a heightened scrutiny on the safety of acetaminophen, widely recognized under the brand name Tylenol, which is a leading cause of acute liver damage in the U.S.
“If you are pregnant or breastfeeding, ask a healthcare professional before using it,” the officials recommended.
However, some medical professionals are urging caution about overstating the risks of Tylenol use during pregnancy. Several international health organizations have encountered and debunked similar claims about the drug’s association with autism, leading to ongoing conversations about the validity of such assertions. Notably, various social media posts reiterating this theme have circulated, with two tweets gaining particular traction lately.
The first tweet from June 2019 celebrated the joys of future parenthood but ominously noted, “Not testing Tylenol used during pregnancy.” The second tweet from March 2017 expressed skepticism about recommending the drug during pregnancy. This latter tweet was reposted by officials from both the White House and the health ministry, sparking some debate.
While a segment of social media users found the initial tweet concerning, others challenged the implied connection to Tylenol and the president’s recent advisory about its usage. Some even suggested the message was misconstrued.
In response to inquiries, a representative from Kenvue, Tylenol’s manufacturer, insisted that the 2017 tweet was taken out of context, stating, “We do not recommend that pregnant women take medication without consulting their doctors.” This aligns with existing guidance on acetaminophen usage.
The current warning mirrors updates made to drug packaging back in 2019, which highlighted risks of “severe skin reactions” and “hepatotoxicity” when taken alongside other substances. A key guideline remains: “If you are pregnant or breastfeeding, ask a medical professional before using it.”
Previously, similar advice was shared in early 2017, emphasizing the need for consultation with a healthcare provider before taking Tylenol during pregnancy.
Regarding the potential correlation between Tylenol and adverse outcomes during pregnancy, a spokesperson for Kemb commented that existing guidance had not changed, reiterating the drug’s safety when used correctly. They stated:
- “Acetaminophen remains the safest pain relief option for pregnant women when necessary.”
- “Our products are safe and effective if used per the product label.”
- “It’s advised that pregnant women do not take over-the-counter medications containing acetaminophen without prior consultation with a healthcare professional.”
Moreover, updates on Tylenol’s FAQ section address concerns regarding its link to autism, asserting that “no reliable scientific evidence” exists to demonstrate a direct cause between acetaminophen use and autism.
Through ongoing research, some studies have pointed towards a connection between prenatal exposure to acetaminophen and neurodevelopmental disorders like autism. For instance, a 2013 study indicated that prolonged exposure could result in adverse developmental outcomes, while another noted potential brain damage from acetaminophen-related oxidative stress in early development.
Overall, amidst the discussions and contradictory messages, Trump remarked, “Don’t take Tylenol. Fight like hell, don’t take it.”
